{"prompt": "['RESPIRATORY', 'Grade 1', 'Grade 2', 'Grade 3', 'Grade 4', 'Bronchospasm (acute)', 'FEV1 or peak flow reduced to', 'FEV1 or peak flow 50% to 69%', 'FEV1 or peak flow 25% to', 'Cyanosis OR FEV1 or peak flow', '70% to 80%', '49%', '< 25% OR Intubation', 'Dyspnea or Respiratory', 'Dyspnea on exertion with no', 'Dyspnea on exertion causing', 'Dyspnea at rest causing', 'Respiratory failure with', 'Distress', 'or minimal interference with', 'greater than minimal interference', 'inability to perform usual', 'ventilatory support indicated', 'usual social & functional', 'with usual social & functional', 'social & functional activities', 'activities', 'activities', 'Pediatric < 14 Years', 'Wheezing OR minimal', 'Nasal flaring OR Intercostal', 'Dyspnea at rest causing', 'Respiratory failure with', 'increase in respiratory rate for', 'retractions OR Pulse oximetry', 'inability to perform usual', 'ventilatory support indicated', 'age', '90% to 95%', 'social & functional activities', 'OR Pulse oximetry < 90%', 'OCULAR/VISUAL', 'Grade 1', 'Grade 2', 'Grade 3', 'Grade 4', 'Uveitis', 'Asymptomatic but detectable', 'Symptomatic anterior uveitis OR', 'Posterior or pan-uveitis OR', 'Disabling visual loss in affected', 'on exam', 'Medical intervention indicated', 'Operative intervention', 'eye(s)', 'indicated', 'Visual Changes (from', 'Visual changes causing no or', 'Visual changes causing greater', 'Visual changes causing', 'Disabling visual loss in affected', 'baseline)', 'minimal interference with', 'than minimal interference with', 'inability to perform usual', 'eye(s)', 'usual social & functional', 'usual social & functional', 'social & functional activities', 'activities', 'activities', 'CRI 15-05 Protocol 13SEP2017', 'Page 61']['SKIN', 'Grade 1', 'Grade 2', 'Grade 3', 'Grade 4', 'Alopecia', 'Thinning detectable by', 'Thinning or patchy hair loss', 'Complete hair loss', 'NA', 'study participant or', 'detectable by health care', 'caregiver (for disabled', 'provider', 'adults)', 'Cutaneous Reaction - Rash', 'Localized macular rash', 'Diffuse macular,', 'Diffuse macular,', 'Extensive or generalized', 'maculopapular, or', 'maculopapular, or morbilliform', 'bullous lesions OR', 'morbilliform rash OR Target', 'rash with vesicles or limited', 'Stevens-Johnson syndrome', 'lesions', 'number of bullae OR', 'OR Ulceration of mucous', 'Superficial ulcerations of', 'membrane involving two', 'mucous membrane limited to', 'or more distinct mucosal', 'one site', 'sites OR Toxic epidermal', 'necrolysis (TEN)', 'Hyperpigmentation', 'Slight or localized', 'Marked or generalized', 'NA', 'NA', 'Hypopigmentation', 'Slight or localized', 'Marked or generalized', 'NA', 'NA', 'Pruritis (itching - no skin', 'Itching causing no or', 'Itching causing greater than', 'Itching causing inability to', 'NA', 'lesions)', 'minimal interference with', 'minimal interference with', 'perform usual social &', '(See also Injection Site', 'usual social & functional', 'usual social & functional', 'functional activities', 'Reactions: Pruritis associated', 'activities', 'activities', 'with injection)', 'CRI 15-05 Protocol 13SEP2017', 'Page 62']['GASTROINTESTINAL', 'Grade 1', 'Grade 2', 'Grade 3', 'Grade 4', 'Anorexia', 'Loss of appetite without', 'Loss of appetite associated with', 'Loss of appetite associated', 'Life-threatening consequences', 'decreased oral intake', 'decreased oral intake without', 'with significant weight loss', 'OR Aggressive intervention', 'significant weight loss', 'indicated [eg, tube feeding or', 'total parenteral nutrition]', 'Ascites', 'Asymptomatic', 'Symptomatic AND Intervention', 'Symptomatic despite', 'Life-threatening consequences', 'indicated (eg, diuretics or', 'intervention', 'therapeutic paracentesis)', 'Cholecystitis', 'NA', 'Symptomatic AND Medical', 'Radiologic, endoscopic, or', 'Life-threatening consequences', 'intervention indicated', 'operative intervention', '(eg, sepsis or perforation)', 'indicated', 'Constipation', 'NA', 'Persistent constipation requiring', 'Obstipation with manual', 'Life-threatening consequences', 'regular use of dietary', 'evacuation indicated', '(eg, obstruction)', 'modifications, laxatives, or', 'enemas', 'Diarrhea', 'Adult and Pediatric', 'Transient or intermittent', 'Persistent episodes of unformed', 'Bloody diarrhea OR Increase', 'Life-threatening consequences', '1 Year', 'episodes of unformed stools', 'to watery stools OR Increase of', 'of > 7 stools per 24-hour', '(eg, hypotensive shock)', 'OR Increase of < 3 stools', '4-6 stools over baseline per', 'period OR IV fluid', 'over baseline/24 hr', '24 hrs.', 'replacement indicated', 'Pediatric < 1 Year', 'Liquid stools (more', 'Liquid stools with increased', 'Liquid stools with moderate', 'Liquid stools resulting in', 'unformed than usual) but', 'number of stools OR Mild', 'dehydration', 'severe dehydration with', 'usual number of stools', 'dehydration', 'aggressive rehydration', 'indicated OR Hypotensive', 'shock', 'CRI 15-05 Protocol 13SEP2017', 'Page 63']\n\n###\n\n", "completion": "END"}